146 related articles for article (PubMed ID: 29984000)
1. Effectiveness and Adverse Effect of Intravenous Lacosamide in Nonconvulsive Status Epilepticus and Acute Repetitive Seizures in Children.
Ngampoopun M; Suwanpakdee P; Jaisupa N; Nabangchang C
Neurol Res Int; 2018; 2018():8432859. PubMed ID: 29984000
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral perampanel in status epilepticus and acute repetitive seizures in children at a tertiary care hospital in Thailand.
Wachiropathum P; Nabangchang C; Likasitthananon N; Suwanpakdee P
Epilepsy Behav; 2021 May; 118():107964. PubMed ID: 33866126
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
Poddar K; Sharma R; Ng YT
Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) study.
Husain AM
Epilepsia; 2013 Sep; 54 Suppl 6():84-8. PubMed ID: 24001083
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
7. Lacosamide in status epilepticus: Update on the TRENdS study.
Husain AM
Epilepsy Behav; 2015 Aug; 49():337-9. PubMed ID: 26152818
[TBL] [Abstract][Full Text] [Related]
8. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
[TBL] [Abstract][Full Text] [Related]
9. Safety of intravenous lacosamide in critically ill children.
Welsh SS; Lin N; Topjian AA; Abend NS
Seizure; 2017 Nov; 52():76-80. PubMed ID: 29017081
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
[TBL] [Abstract][Full Text] [Related]
11. Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus.
Creed JA; Son J; Farjat AE; Swisher CB
Seizure; 2018 Jan; 54():45-50. PubMed ID: 29248799
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and treatments effectiveness in status epilepticus resolved by antiepileptic drugs: A five-year observational study.
Orlandi N; Giovannini G; Rossi J; Cioclu MC; Meletti S
Epilepsia Open; 2020 Jun; 5(2):166-175. PubMed ID: 32524042
[TBL] [Abstract][Full Text] [Related]
13. Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus.
Pizzi MA; Kamireddi P; Tatum WO; Shih JJ; Jackson DA; Freeman WD
J Intensive Care; 2017; 5():54. PubMed ID: 28808577
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
15. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
16. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
McTague A; Kneen R; Kumar R; Spinty S; Appleton R
Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
[TBL] [Abstract][Full Text] [Related]
18. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
Khongkhatithum C; Thampratankul L; Wiwattanadittakul N; Visudtibhan A
Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Lacosamide Therapy for Pediatric Patients With Cluster Seizures.
Matsuura R; Hamano SI; Kikuchi K; Takeda R; Takeuchi H; Hirata Y; Koichihara R; Niitsu T; Ueta I; Oka A
Pediatr Neurol; 2024 May; 157():1-4. PubMed ID: 38815509
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
Pasha I; Kamate M; Didagi SK
Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
